Expert Consensus on the Diagnosis and Treatment of Anticancer Drug-Induced Interstitial Lung Disease  

作　　者：无 Fei MA Hua-ping DAI 

机构地区：[1]Anticancer Drug-induced Interstitial Lung Disease Diagnosis and Treatment Group,China [2]Interstitial Lung Diseases Panel,Chinese Medical Association-Chinese Thoracic Society and Chinese Medical Doctor Association-Chinese Association of Chest Physicians,China [3]Department of Medical Oncology,National Cancer Center,National Clinical Research Center for Cancer,Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 10021,China [4]Department of Pulmonary and Critical Care Medicine,China-Japan Friendship Hospital,National Center for Respiratory Medicine,Chinese Academy of Medical Sciences,Beijing 100029,China

出　　处：《Current Medical Science》2023年第1期1-12,共12页当代医学科学（英文）

基　　金：supported by grants from CAMS Innovation Fund for Medical Sciences(CIFMS)(No.2021-I2M-1-014)and National Key R&D Program of China(No.2021YFC2500700).

摘　　要：Drug-induced interstitial lung disease(DILD)is the most common pulmonary adverse event of anticancer drugs.In recent years,the incidence of anticancer DILD has gradually increased with the rapid development of novel anticancer agents.Due to the diverse clinical manifestations and the lack of specific diagnostic criteria,DILD is difficult to diagnose and may even become fatal if not treated properly.Herein,a multidisciplinary group of experts from oncology,respiratory,imaging,pharmacology,pathology,and radiology departments in China has reached the“expert consensus on the diagnosis and treatment of anticancer DILD”after several rounds of a comprehensive investigation.This consensus aims to improve the awareness of clinicians and provide recommendations for the early screening,diagnosis,and treatment of anticancer DILD.This consensus also emphasizes the importance of multidisciplinary collaboration while managing DILD.

关 键 词：drug-induced interstitial lung disease anticancer drug DIAGNOSIS TREATMENT 

分 类 号：R979.1[医药卫生—药品]